Us Preimplantation Genetic Diagnosis Market Size By Applications, By Type, By End-User, By Deployment & By Technology 2032
Preimplantation Genetic Diagnosis Market was valued at USD 2.30 Billion in 2022 and is projected to reach USD 5.40 Billion by 2030, growing at a CAGR of 12.00% from 2024 to 2030.
Exploring the US Preimplantation Genetic Diagnosis (PGD) Market: Trends, Challenges, and Personal Insights
The US Preimplantation Genetic Diagnosis (PGD) market has witnessed significant growth, driven by advancements in reproductive technologies and increasing demand for genetic screening. PGD, a procedure used alongside in vitro fertilization (IVF), allows for the detection of genetic abnormalities in embryos before implantation, thereby reducing the risk of hereditary diseases.
In my personal experience, navigating the PGD process was both enlightening and challenging. The procedure involves several intricate steps:
IVF Cycle Initiation: Undergoing hormonal treatments to stimulate egg production.
Egg Retrieval and Fertilization: Collecting eggs and fertilizing them with sperm in a controlled environment.
Embryo Biopsy: Extracting cells from embryos for genetic analysis.
Genetic Testing: Screening embryos for specific genetic disorders.
Embryo Transfer: Implanting healthy embryos into the uterus.
Throughout this journey, I encountered both hope and uncertainty, especially when faced with the possibility of discarding embryos with detected abnormalities. The emotional and ethical considerations were profound, underscoring the complexity of reproductive choices.
Financially, the PGD process can be burdensome. On average, a single PGD cycle in the US costs between $10,000 to $15,000, significantly higher than standard IVF procedures. This expense often deters many prospective parents, as insurance coverage for PGD remains limited.
Ethical debates surrounding PGD are prevalent. The potential for "designer babies" and the selection of non-medical traits, such as gender or eye color, raises moral questions. In California, for instance, some clinics offer services that allow selection of a child's sex and, occasionally, eye color, attracting individuals from countries where such practices are prohibited. This trend highlights the fine line between medical necessity and genetic preference.
Despite these challenges, the PGD market continues to expand. The global preimplantation genetic testing market is projected to grow from $0.7 billion in 2023 to $1.2 billion by 2028, at a compound annual growth rate (CAGR) of 11.4%. This growth is attributed to factors such as declining fertility rates, increasing maternal age, and rising public awareness about genetic testing.
In conclusion, while the US PGD market offers promising solutions for preventing genetic disorders, it also presents financial, ethical, and emotional challenges. My personal journey through the PGD process highlighted the importance of comprehensive counseling and support for individuals and couples considering this path.
Get an In-Depth Research Analysis of the Global Preimplantation Genetic Diagnosis Market Size And Forecast [2025-2032]
Illumina
Inc
Thermo Fisher Scientific Inc
Agilent Technologies
Inc
Perkinelmer
Inc
Coopersurgical
ABBott Laboratories
Natera
Inc
Rubicon Genomics
Oxford Gene Technology
Yikon Genomics
Scigene
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the Global Preimplantation Genetic Diagnosis Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the Global Preimplantation Genetic Diagnosis Market
Polymerase Chain Reaction (PCR)
Fluorescence In Situ Hybridization (FISH)
Next-Generation Sequencing (NGS)
Microarrays
Genetic Disease Screening
Sex Selection
HLA Typing
Fertility Clinics
Diagnostic Laboratories
Research Institutes
In vitro Fertilization (IVF)
Intracytoplasmic Sperm Injection (ICSI)
Reagents and Kits
Instruments
Services
Global (United States, Global and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ Preimplantation Genetic Diagnosis Market Research Analysis
1. Introduction of the Global Preimplantation Genetic Diagnosis Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Global Preimplantation Genetic Diagnosis Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Global Preimplantation Genetic Diagnosis Market, By Type
6. Global Preimplantation Genetic Diagnosis Market, By Application
7. Global Preimplantation Genetic Diagnosis Market, By Geography
Global
Europe
Asia Pacific
Rest of the World
8. Global Preimplantation Genetic Diagnosis Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Global Research and Consulting firm servicing over 5000+ global clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/